prevalÊncia de doadores com marcadores da hepatite b detectados pela triagem sorolÓgica no instituto onco-hematolÓgico de anÁpolis em 2012 e 2013

Clicks: 336
ID: 158649
2015
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Objective: To determine the prevalence of serological markers for hepatitis B in blood donors of Instituto Onco-Hematológico de Anápolis, correlating to age, gender and marital status of the donors with the results of serological screening for hepatitis B. Methods: A retrospective descriptive study was performed by evaluating the data from laboratory tests of markers of hepatitis B serological screening performed in Instituto Onco-Hematológico de Anápolis during the years 2012 and 2013. Data for the months of January to December in both years were collected. The markers were Anti-HBc Total and HBsAg. The estimated population sample (n) was 31,537 peoples. The variables included: age, gender, marital status. The Chi-Square (χ2) or Fisher's exact test were used to analyze categorical variables. Results: There was a low prevalence of markers evaluated, as regards the Anti-HBc reactivity with increasing age. It was observed an association of positivity with serological markers in relation to female and unmarried. Conclusions: Strategies for attracting donors, as well as preventive measures constitute important ways to ensure low virus circulation in the region, ensuring lower costs by performing the serologic screening.
Reference Key
oliveira2015revistaprevalncia Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Leonardo Tavares de Oliveira;Rayanne de Deus Guedes;Jozelia Rêgo;Cleonice Maria Garcia de Souza;Thiago Vilarinho Tavares
Journal journal of experimental psychology human perception and performance
Year 2015
DOI DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.